These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37726329)

  • 41. The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.
    Aksenova AY; Likhachev IV; Grishin SY; Galzitskaya OV
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
    Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility.
    Valério M; Borges-Araújo L; Melo MN; Lousa D; Soares CM
    Front Med Technol; 2022; 4():1009451. PubMed ID: 36277437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting the Receptor-Binding Motif of SARS-CoV-2 with D-Peptides Mimicking the ACE2 Binding Helix: Lessons for Inhibiting Omicron and Future Variants of Concern.
    Valiente PA; Nim S; Lee J; Kim S; Kim PM
    J Chem Inf Model; 2022 Aug; 62(15):3618-3626. PubMed ID: 35875887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SCORe: SARS-CoV-2 Omicron Variant RBD-Binding DNA Aptamer for Multiplexed Rapid Detection and Pseudovirus Neutralization.
    Yang LF; Kacherovsky N; Liang J; Salipante SJ; Pun SH
    Anal Chem; 2022 Sep; 94(37):12683-12690. PubMed ID: 35972202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.
    Sabzian-Molaei F; Hosseini S; Alipour A; Ghaderi H; Fotouhi-Chahouki F; Hadi A; Shahsavarani H
    Phytomedicine; 2023 Mar; 111():154648. PubMed ID: 36681052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-CoV-2 vaccine breakthrough infections (VBI) by Omicron variant (B.1.1.529) and consequences in structural and functional impact.
    Abduljaleel Z; Melebari S; Athar M; Dehlawi S; Udhaya Kumar S; Aziz SA; Dannoun AI; Malik SM; Thasleem J; George Priya Doss C
    Cell Signal; 2023 Sep; 109():110798. PubMed ID: 37423342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain.
    Lupala CS; Kumar V; Su XD; Wu C; Liu H
    Comput Biol Med; 2022 Feb; 141():105017. PubMed ID: 34758907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
    Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
    J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2.
    Han P; Li L; Liu S; Wang Q; Zhang D; Xu Z; Han P; Li X; Peng Q; Su C; Huang B; Li D; Zhang R; Tian M; Fu L; Gao Y; Zhao X; Liu K; Qi J; Gao GF; Wang P
    Cell; 2022 Feb; 185(4):630-640.e10. PubMed ID: 35093192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
    Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
    Front Immunol; 2022; 13():954435. PubMed ID: 36569921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2.
    Philip AM; Ahmed WS; Biswas KH
    Comput Struct Biotechnol J; 2023; 21():1966-1977. PubMed ID: 36936816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2.
    Fazekas Z; Menyhárd DK; Perczel A
    J Chem Inf Model; 2022 Aug; 62(16):3844-3853. PubMed ID: 35849759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
    Wang WB; Liang Y; Jin YQ; Zhang J; Su JG; Li QM
    J Mol Graph Model; 2021 Dec; 109():108035. PubMed ID: 34562851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.
    Liu H; Wei P; Aviszus K; Zhang Q; Linderberger J; Yang J; Liu J; Chen Z; Waheed H; Reynoso L; Downey GP; Frankel SK; Kappler JW; Marrack P; Zhang G
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant.
    Bayani F; Safaei Hashkavaei N; Uversky VN; Mozaffari-Jovin S; Sefidbakht Y
    Comput Biol Med; 2022 Aug; 147():105735. PubMed ID: 35767919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets.
    Verkhivker G; Agajanian S; Kassab R; Krishnan K
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.
    Borkotoky S; Dey D; Hazarika Z
    Mol Biol Rep; 2023 Mar; 50(3):2713-2721. PubMed ID: 36562937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.